NDC 50419-188-81 Magnevist

Gadopentetate Dimeglumine

  1. Labeler Index
  2. Bayer Healthcare Pharmaceuticals Inc.
  3. 50419-188
  4. NDC Code: 50419-188-81 Magnevist

NDC Package Code 50419-188-81

The NDC Code 50419-188-81 is assigned to a package of 2 carton in 1 box > 10 vial, single-dose in 1 carton > 5 ml in 1 vial, single-dose of Magnevist, a human prescription drug labeled by Bayer Healthcare Pharmaceuticals Inc.. The product's dosage form is injection and is administered via intravenous form.

Field Name Field Value
NDC Code 50419-188-81
Package Description 2 CARTON in 1 BOX > 10 VIAL, SINGLE-DOSE in 1 CARTON > 5 mL in 1 VIAL, SINGLE-DOSE
Proprietary Name Magnevist What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Gadopentetate Dimeglumine What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
11-Digit NDC Billing Format 50419018881 NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
Billing Unit ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Product Type Human Prescription Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Labeler Name Bayer Healthcare Pharmaceuticals Inc.
Dosage Form Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s)
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
  • GADOPENTETATE DIMEGLUMINE 469.01 mg/mL
  • GADOPENTETATE DIMEGLUMINE 469.01 mg/mL
Sample Package No Sample Package?
This field Indicates whether this package is a sample packaging or not.
Marketing Category NDA - A product marketed under an approved New Drug Application. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
FDA Application Number NDA021037 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Start Marketing Date 12-14-2010 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Start Marketing Date 05-30-2022 What is the End Marketing Date?
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Exclude Flag N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

NDC Code Structure

  • 50419 - Bayer Healthcare Pharmaceuticals Inc.
    • 50419-188 - Magnevist
      • 50419-188-81 - 2 CARTON in 1 BOX

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

NDC HCPCS Crosswalk

This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

NDC 50419-188-81 HCPCS crosswalk information with package details and bill units information.

NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
50419018881A9579Gad-base mr contrast nos,1ml1 ML5205100

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for Magnevist with product NDC 50419-188.

NDC Package CodePackage Description
50419-188-0120 CARTON in 1 BOX > 1 VIAL, SINGLE-DOSE in 1 CARTON > 10 mL in 1 VIAL, SINGLE-DOSE
50419-188-0220 CARTON in 1 BOX > 1 VIAL, SINGLE-DOSE in 1 CARTON > 20 mL in 1 VIAL, SINGLE-DOSE
50419-188-0520 CARTON in 1 BOX > 1 VIAL, SINGLE-DOSE in 1 CARTON > 5 mL in 1 VIAL, SINGLE-DOSE
50419-188-1110 VIAL, PHARMACY BULK PACKAGE in 1 BOX > 100 mL in 1 VIAL, PHARMACY BULK PACKAGE
50419-188-1520 CARTON in 1 BOX > 1 VIAL, SINGLE-DOSE in 1 CARTON > 15 mL in 1 VIAL, SINGLE-DOSE
50419-188-365 SYRINGE in 1 BOX > 10 mL in 1 SYRINGE
50419-188-375 SYRINGE in 1 BOX > 15 mL in 1 SYRINGE
50419-188-385 SYRINGE in 1 BOX > 20 mL in 1 SYRINGE
50419-188-4020 CARTON in 1 BOX > 1 VIAL, SINGLE-DOSE in 1 CARTON > 5 mL in 1 VIAL, SINGLE-DOSE
50419-188-4220 CARTON in 1 BOX > 1 VIAL, SINGLE-DOSE in 1 CARTON > 10 mL in 1 VIAL, SINGLE-DOSE
50419-188-435 SYRINGE in 1 BOX > 10 mL in 1 SYRINGE
50419-188-4420 CARTON in 1 BOX > 20 VIAL, SINGLE-DOSE in 1 CARTON > 15 mL in 1 VIAL, SINGLE-DOSE
50419-188-455 SYRINGE in 1 BOX > 15 mL in 1 SYRINGE
50419-188-4620 CARTON in 1 BOX > 1 VIAL, SINGLE-DOSE in 1 CARTON > 20 mL in 1 VIAL, SINGLE-DOSE
50419-188-475 SYRINGE in 1 BOX > 20 mL in 1 SYRINGE
50419-188-5810 VIAL, PHARMACY BULK PACKAGE in 1 BOX > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE
50419-188-822 CARTON in 1 BOX > 10 VIAL, SINGLE-DOSE in 1 CARTON > 10 mL in 1 VIAL, SINGLE-DOSE
50419-188-832 CARTON in 1 BOX > 10 VIAL, SINGLE-DOSE in 1 CARTON > 15 mL in 1 VIAL, SINGLE-DOSE
50419-188-842 CARTON in 1 BOX > 10 VIAL, SINGLE-DOSE in 1 CARTON > 20 mL in 1 VIAL, SINGLE-DOSE

* Please review the disclaimer below.